Search results
Scientists track 'doubling' in origin of cancer cells
Medical Xpress· 1 day ago"An enduring question among scientists in the cancer field is: How do cancer cell genomes get so bad?" says Sergi Regot, Ph.D., associate ...
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 2 days agoSide effects of antibody-drug conjugates vary depending on the antibody and potency of chemotherapy...
When do you need to start getting a mammogram? Here's what new recommendations say.
Yahoo Life Style via AOL· 4 days agocancer is easier to treat if it’s found earlier; we’re able to spare women extra surgeries and...
Atossa and Weill Cornell expand breast cancer drug research By Investing.com
Investing.com· 4 days agoThe research will investigate the synergy between (Z)-endoxifen, a potent Selective Estrogen...
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 2 days agoForkhead box protein M1 (FOXM1) is often overexpressed in human cancers and strongly associated with therapy resistance and less good patient survival. The chemotherapy options ...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 18 hours agoMariana hasn’t yet disclosed the target of its small cell lung cancer treatment, but the candidate uses actinium, which a number of other companies,...
PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision...
FOX 4 Kansas City· 2 days agoPrelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat Whitworth as its ...
USPSTF Recommendation: Screening for Breast Cancer
Journal of the American Medical Association· 4 days agoThis 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and concludes that evidence ...
Earnings call: Puma Biotechnology reports Q1 2024 results, NERLYNX sales dip
Investing.com· 1 day agoPuma Biotechnology, Inc. (NASDAQ: PBYI ) discussed its first-quarter financial results for 2024,...
Head Size-Related Genetic Variants Coincide With Cancer Genes, Pathways
GenomeWeb News· 14 hours agoA large genome-wide association study meta-analysis uncovered dozens of head size-linked loci, including sites that overlapped with macrocephaly and cancer-related genes and processes.
